Nyxoah SA
NYXH- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001857190
No open-market purchases or sales by Nyxoah SA insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $37.5M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Nyxoah SA as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- −1 vs. Q3 2023
- Shares held
- 2.10M
- −481.9K (−18.7%) vs. Q3 2023
- Total value
- $9.76M
- −$8.46M (−46.5%) vs. Q3 2023
- New holders
- 0
- 6 more added
- Sold out
- 1
- 3 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NYXH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $37.5M |
| Q1 2026 | 34 | $10.4M |
| Q4 2025 | 33 | $16.8M |
| Q3 2025 | 32 | $13.5M |
| Q2 2025 | 31 | $29.2M |
| Q1 2025 | 26 | $41.8M |
| Q4 2024 | 22 | $54.4M |
| Q3 2024 | 20 | $39.1M |
| Q2 2024 | 21 | $29.4M |
| Q1 2024 | 19 | $29.3M |
| Q4 2023 | 16 | $9.76M |
| Q3 2023 | 17 | $18.2M |
| Q2 2023 | 16 | $21.1M |
| Q1 2023 | 18 | $17.6M |
| Q4 2022 | 18 | $13.3M |
| Q3 2022 | 20 | $18.1M |
| Q2 2022 | 22 | $28.1M |
| Q1 2022 | 18 | $59.1M |
| Q4 2021 | 16 | $60.9M |
| Q3 2021 | 18 | $75.1M |
| Q2 2021 | 1 | $5.75M |
| Q1 2021 | 1 | $7.18M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Nyxoah SA; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 653,984 | $3.03M | 0.00% | +1,121+0.2% | Added |
| Opaleye Management Inc. | 344,800 | $1.60M | 0.43% | −97,096−22.0% | Reduced |
| AXA S.A. | 221,700 | $1.03M | 0.00% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 200,076 | $928.4K | 0.24% | 00.0% | Unchanged |
| Putnam Investments LLC | 192,942 | $895.3K | 0.00% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 174,842 | $811.3K | 0.01% | −225,414−56.3% | Reduced |
| Rossmore Private Capital | 117,940 | $554.9K | 0.08% | 00.0% | Unchanged |
| Pura Vida Investments, LLC | 111,467 | $522.5K | 0.57% | 00.0% | Unchanged |
| DekaBank Deutsche Girozentrale | 33,200 | $150.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 18,208 | $84.5K | 0.00% | −39,559−68.5% | Reduced |
| ExodusPoint Capital Management, LP | 17,023 | $79.0K | 0.00% | +813+5.0% | Added |
| Citigroup Inc | 6,688 | $31.5K | 0.00% | +5,959+817.4% | Added |
| Barclays PLC | 4,103 | $19.0K | 0.00% | +3,843+1,478.1% | Added |
| Bank of America Corp | 3,339 | $15.5K | 0.00% | +2,797+516.1% | Added |
| UBS Group AG | 230 | $1.07K | 0.00% | +25+12.2% | Added |
| Wells Fargo & Company | 17 | $80 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 0 | $0 | 0.00% | −134,427−100.0% | Sold out |